25 of the Best Pediatric Hematologist Oncologists Near Me

Dr. Oshrine specializes in blood and marrow transplants as a pediatric hematologist/oncologist in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. His clinical focus is in the treatment of high-risk leukemias with blood and marrow transplantation, and his research focus is in immune recovery after transplant. He joined the hospital in 2014 after completing a fellowship in pediatric hematology/oncology at the Children’s Hospital of Philadelphia. He received the Excellence in Service & Professionalism Award in the 2018 Johns Hopkins Medicine Clinical Excellence Awards. Dr. Oshrine is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Graft Versus Host Disease (GvHD), Juvenile Myelomonocytic Leukemia (JMML), Bone Marrow Transplant, and Gastrostomy. Dr. Oshrine is board certified in American Board Of Pediatrics. Dr. Oshrine is currently accepting new patients.

Alexander Boucher is a Pediatric Hematologist Oncology specialist and a Hematologist practicing medicine in Minneapolis, Minnesota. Dr. Boucher is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Sickle Cell Disease, Essential Thrombocythemia, Islet Cell Transplantation, and Pancreatectomy. Dr. Boucher is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021, Internal Medicine: American Board Of Internal Medicine, 2016, and Pediatrics: American Board Of Pediatrics, 2017. Dr. Boucher is currently accepting new patients.

Joseph Neglia is a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Neglia is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, Hereditary Retinoblastoma, and Splenectomy. Dr. Neglia is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1986. Dr. Neglia is currently accepting new patients.

Dr. Neethu Menon finished her medical degree and a residency at Maulana Azad Medical College in New Delhi, India. She completed a second residency at the University of Arizona College of Medicine, followed by a fellowship in pediatric hematology-oncology at UT Southwestern Medical Center in Dallas. Dr. Menon has been in practice since 2006. Board certified in both pediatrics and pediatric hematology-oncology, she treats children and young women for a variety of blood disorders. Her primary clinical interests include anemia, sickle cell disease, bleeding disorders and thrombosis. She is affiliated with the pediatrics faculty at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) and has contributed, written and presented on hematology-related topics including sickle cell anemia, thrombosis and bleeding disorders. Away from her practice, Dr. Menon enjoys music and practices yoga. Dr. Menon is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Anemia, Hemoglobinopathy, and Congenital Hemolytic Anemia. Dr. Menon is currently accepting new patients.

My interests are in Pediatric, Adolescent and Young adult oncology and Benign Hematology including Leukemia, Lymphoma, Solid Tumors, Sarcoma, Brain Tumors, RBC and Platelet Disorders. Sickle Cell Disease, and Bleeding and Clotting Disorders. Dr. Hanmod is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Histiocytosis, Reticulohistiocytoma, Hepatoblastoma, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Hanmod is board certified in American Board Of Pediatrics/Hematology-Oncology and American Board Of Pediatrics. Dr. Hanmod is currently accepting new patients.

My clinical and research focus is in blood and marrow transplantation. In addition to treating my young cancer patients, throughout my medical career I have had an active research laboratory in cancer and transplant immunology. I have been fortunate to see our research findings translate into clinical trials with real benefits for our patients. A good day for me has to start with a 5-10 mile run starting at 5:00 to beat the heat. Dr. Katsanis is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Dyserythropoietic Anemia and Thrombocytopenia, Leukemia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant. Dr. Katsanis is board certified in American Board Of Pediatrics/Hematology-Oncology and American Board Of Pediatrics. Dr. Katsanis is currently accepting new patients.

Lucie Turcotte is a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Turcotte is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Graft Versus Host Disease (GvHD), and Langerhans Cell Histiocytosis. Dr. Turcotte is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2015 and Pediatrics: American Board Of Pediatrics, 2010. Dr. Turcotte is currently accepting new patients.

Miriam Garcia is a Pediatric Hematologist Oncology provider practicing medicine in Houston, Texas. Dr. Garcia is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Febrile Neutropenia, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Ataxia-Telangiectasia. Dr. Garcia is currently accepting new patients.

Aditi Dhir is a Pediatric Hematologist Oncology specialist and a Pediatrics provider practicing medicine in Miami, Florida. Dr. Dhir is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Osteosarcoma, Ewing Sarcoma, Hepatoblastoma, and Liver Embolization. Dr. Dhir is currently accepting new patients.

Lea Mayer is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Dr. Mayer is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Hereditary Neuroblastoma, Ewing Sarcoma, and Osteosarcoma. Dr. Mayer is board certified in Oncology Nursing Certification Corporation, 2015 and Primary Care Certified Pediatric Nurse Practitioner (CPNP-PC): Pediatric Nursing Certification Board, 2010.

Dr. Resar's studies molecular mechanisms leading to cancer, blood diseases, sickle cell anemia, hemophilia and other coagulopathies. Her research focuses on the HMG-I/Y gene family, which is widely overexpressed and functions as oncogenes in human cancers. Her laboratory recently developed transgenic mice overexpressing HMG-I; all mice develop aggressive lymphoid malignancy similar to leukemia and lymphoma in humans. Her studies also demonstrate that this gene is overexpressed in human lymphoid and other malignancies. Translational studies are underway to determine if overexpression of HMG-I is a marker for more aggressive human cancers. Resar's long-term goal is to develop more rational therapies that interfere with HMG-I/Y function in neoplastic transformation. Dr. Resar is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Acute Eosinophilic Pneumonia, Hypereosinophilic Syndrome, Anemia, and Thrombocytopenia. Dr. Resar is board certified in American Board Of Pediatrics.

Dr. Michelle Hudspeth is a 1999 graduate of the MUSC College of Medicine and completed her residency, chief residency, and fellowship at the Johns Hopkins Hospital and the National Cancer Institute. She is the division chief for pediatric hematology/oncology and is the director of the pediatric blood and marrow transplant program and the quality director for the combined adult and pediatric blood and marrow transplant program. Her main clinical focus is transplantation, including haploidentical, related and unrelated allogeneic, cord blood, and autologous donor sources. She is the institutional principal investigator for Pediatric Blood and Marrow Transplant Consortium trials. She is a member of the Pediatric Blood and Marrow Transplant Consortium GVHD committee and supportive care committee. She also serves on several working committees (GVHD, pediatric cancer, immune deficiencies/inborn errors of metabolism) for the Center for International Blood and Marrow Transplant Research. Her clinical research includes multiple aspects of transplantation, including a clinical trial incorporating pravastatin for matched related donor transplants for sickle cell disease. Dr. Hudspeth is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Infantile Neutropenia, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Thymectomy. Dr. Hudspeth is currently accepting new patients.

Luca Szalontay is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. Dr. Szalontay is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Glioma, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Brain Stem Cancer. Dr. Szalontay is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021 and Pediatrics: American Board Of Pediatrics, 2015. Dr. Szalontay is currently accepting new patients.

Urania Dagalakis, MD, MHSc, specializes in pediatric oncology and hematology. She completed her clinical training at Johns Hopkins University and conducted her research work within the National Cancer Institute of the National Institutes of Health. Due to her research background she specializes in caring for children with rare tumors and hereditary cancer syndromes. Dr. Dagalakis is the director of the Cancer Genetics Clinic at Children’s National Hospital. She is also an assistant professor of pediatrics at The George Washington University School of Medicine and Health Sciences and a physician in the Center for Cancer and Blood Disorders. She is committed to empowering families with knowledge, supporting survivorship and leading innovations in personalized cancer care. Her work bridges compassionate patient care with clinical research focused on improving outcomes for children with genetic cancer predispositions. Dr. Dagalakis is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Hemoglobin SC Disease and Immune Thrombocytopenic Purpura (ITP). Dr. Dagalakis is board certified in Pediatrics: American Board Of Pediatrics, 2023.

Shelby Smith is a Pediatric Hematologist Oncology specialist and a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Smith is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL). Dr. Smith is board certified in Pediatric Nursing Certification Board, 2016.

Dr. Donald Small is the Kyle Haydock Professor of Oncology. He holds joint appointments in Pediatrics and Cellular and Molecular Medicine and Human Genetics. He also directs the Johns Hopkins/National Cancer Institute Pediatric Hematology/Oncology Fellowship program. Dr. Small received his undergraduate, and then M.D. and Ph.D. degrees from the Johns Hopkins University in 1979 and 1985. His Ph.D. research was conducted with Bert Vogelstein in the Oncology Department and his postdoctoral research with Tom Kelly in the Molecular Biology and Genetics Department. He trained in pediatrics and pediatric hematology/oncology at Johns Hopkins and joined the faculty in 1990. Dr. Small’s laboratory was the first to clone the human FLT3 gene that is the most frequently mutated gene in acute myeloid leukemia (AML) and results in very poor chances of cure for these patients. The investigations of FLT3 led Dr. Small and his team to discover drugs able to inhibit the cancer-generating activity of this important gene. His laboratory showed that a new class of drugs known as tyrosine kinase inhibitors could kill FLT3-affected cells, thus developing one of the earliest molecularly targeted cancer therapies. They then developed a test that enabled them to screen a host of additional kinase inhibitors and find several with great potency against FLT3. His group also led the first clinical trials investigating the use of a FLT3 inhibitor in adult relapsed and refractory FLT3 mutant AML, and determined how best to combine these drugs with chemotherapy. They also helped design the first pediatric trials of FLT3 inhibitors in pediatric AML and infant ALL. Dr. Small’s lab continues to investigate leukemic processes and the role of stem cells in governing the activities of the FLT3 gene in leukemia. Dr. Small is highly rated in 1 condition, according to our data. His clinical expertise encompasses Leukemia and Acute Lymphoblastic Leukemia (ALL). Dr. Small is currently accepting new patients.

Shana S. Jacobs, MD, is a member of the Leukemia/Lymphoma Program and the Pediatric Advanced Needs Assessment and Care Team (PANDA). Dr. Jacobs' clinical focus is on leukemia and lymphoma and she has an interest in palliative and supportive care. Publications PubMed. Dr. Jacobs is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Osteosarcoma, Malignant Peripheral Nerve Sheath Tumor, and Bone Marrow Transplant. Dr. Jacobs is board certified in Pediatrics: American Board Of Pediatrics, 2002, American Board Of Pediatrics, 2010, and Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006.

Hyojeong Han is a Pediatric Hematologist Oncology specialist and a Transfusion Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Han is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Anemia, and Hemolytic Anemia. Dr. Han is board certified in American Board Of Pathology, 2021, American Board Of Pediatrics, 2021, and American Board Of Pediatrics, 2016. Dr. Han is currently accepting new patients.

Sayani Tewari is a Pediatric Hematologist Oncology provider practicing medicine in Dover, Delaware. Dr. Tewari is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Tetra-Amelia Syndrome, Alpha Thalassemia, Eyelid Bump, and Thalassemia. Dr. Tewari is board certified in American Board Of Pediatrics. Dr. Tewari is currently accepting new patients.

Nita L. Seibel, MD, is a board-certified pediatrician and pediatric hematologist-oncologist. After graduating from the Ohio State University College of Medicine in 1988, she completed her internship and residency at the Ohio State University Children’s Hospital in 1984. Dr. Seibel completed a fellowship in pediatric hematology-oncology at the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health in 1987. She joined the faculty of Children's National Hospital in 1988 and is a professor of pediatrics at the George Washington University School of Medicine & Health Sciences. While at Children's National, Dr. Seibel has served for over 15 years on the Institutional Review Board, as Director of the Hematology/Oncology Training Program for nine years and as Principal Investigator for Children's Oncology Group. Dr. Seibel has chaired numerous studies for the Children’s Oncology Group including chairing the Phase I Data Safety Monitoring Committee and served as vice-chair for Phase I agents. Dr. Seibel was also a member of the National Wilms Tumor Study and later the COG Renal Tumor Committee. Dr. Seibel's areas of special interest are: Wilms tumor, bone tumors, ALL, and adolescent and young adult oncology as well as late effects. She also has a special interest in Acute Lymphoblastic Leukemia in adolescents and young adults and anti-fungal agents. Dr. Seibel is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult Soft Tissue Sarcoma, and Infantile Neutropenia. Dr. Seibel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1986.

John Leister is a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Leister is highly rated in 1 condition, according to our data. His clinical expertise encompasses Ligneous Conjunctivitis, Evans Syndrome, Anemia, and Immune Thrombocytopenic Purpura (ITP). Dr. Leister is board certified in Pediatrics: American Board Of Pediatrics, 2021. Dr. Leister is currently accepting new patients.

Robin Williams is a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Williams is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Megakaryoblastic Leukemia, Evans Syndrome, Retinoblastoma, and Hereditary Retinoblastoma. Dr. Williams is board certified in Pediatrics: American Board Of Pediatrics, 2014 and Pediatric Hematology-Oncology: American Board Of Pediatrics, 2019. Dr. Williams is currently accepting new patients.

Vanessa Salinas-Luna is a Pediatric Hematologist Oncology provider practicing medicine in Orange, California. Her clinical expertise encompasses Beta Thalassemia, Hemophilia A, Hemophilic Arthropathy, and Ataxia-Pancytopenia Syndrome. Dr. Salinas-Luna is currently accepting new patients.

Melanie Degliuomini is a Pediatric Hematologist Oncology provider practicing medicine in Hackensack, New Jersey. Her clinical expertise encompasses Acute Megakaryoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Febrile Neutropenia, Hemophilic Arthropathy, and Bone Marrow Aspiration. Dr. Degliuomini is board certified in American Board Of Pediatrics. Dr. Degliuomini is currently accepting new patients.

Katherine Armstrong is a Pediatric Hematologist Oncology provider practicing medicine in Hackensack, New Jersey. Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Febrile Neutropenia, Renal Vein Thrombosis, Acute Megakaryoblastic Leukemia, and Bone Marrow Aspiration. Dr. Armstrong is board certified in American Board Of Pediatrics. Dr. Armstrong is currently accepting new patients.